News

In this interview, Aleix Sala-Vila, PhD, shares more on his recent project involving data from global cohorts on links between omega-3 biomarkers and incident dementia.

Ashwagandha is finding its way into more products as research grows on the ingredient's health benefits, and formulators push the boundaries of alternative dosage formats.

The FDA initiated an examination of the safety of the chemical preservative butylated hydroxyanisole (BHA) through a review of scientific information.

Nutritional Outlook interviews Scott Dicker, senior director of market insights at SPINS to discuss the 2026 Ingredients to Watch. Dicker unpacks sales trends in the nutraceutical space and what they mean for product formulators and marketers. This is Part 1 of a two-part conversation in which Dicker discusses what is driving sales growth of creatine and protein.

A growing number of innovative nutraceutical solutions are coming to market that help users deal with everyday stressors to improve sleep and quality of life.

Nutritional Outlook interviews Scott Dicker, senior director of market insights at SPINS to discuss the 2026 Ingredients to Watch. Dicker unpacks sales trends in the nutraceutical space and what they mean for product formulators and marketers. This year's Ingredients to Watch include ashwagandha, colostrum, creatine, and protein.

In this interview, Aleix Sala-Vila, PhD, explains the effect of diets on healthy aging, highlighting a study on supplementation with walnuts.

In this interview, Andrea Fuso, PhD, explains recent research the role of vitamin K in brain health, epigenetics, and its potential combination with S-adenosyl-L-methionine (SAMe).

The company is developing solutions for omega powders, berberine, CoQ10, vitamin C, and creatine powders, while also expanding R&D capabilities.

In this interview, Aleix Sala-Vila, PhD, explains research on the effects of the Mediterranean diet on cardiovascular disease and cognitive decline.

Nutritional Outlook, in collaboration with market research firm SPINS, provides a deep dive into 2026's top trending ingredients in the nutraceutical space. This year's Ingredients to Watch focuses on ashwagandha, colostrum, creatine, and protein, with expert insights and detailed sales data.

In this interview, Aleix Sala-Vila, PhD, explains how research suggests ALA from foods like walnuts may support cardiovascular outcomes.

Expert insights on developing flavor trends driving consumer engagement.

In this interview, Aleix Sala-Vila shares his research that links higher omega-3 levels with reduced atherosclerosis, improved survival after cardiac events, and better heart failure outcomes.

The U.S. Food and Drug Administration will allow products made without petroleum-based synthetic dyes to carry the claim, and also approved two more natural color additives.

The new partnership aims to expand distribution across Europe, the Middle East, and Africa to support food innovation, plant-based development, and evolving consumer demands.

Congressman Nick Langworthy introduces the Dietary Supplement Regulatory Uniformity Act to reaffirm FDA oversight and end the "patchwork" of conflicting state laws.

The new Lacprodan BLG-100 Acidic whey protein aims to offer increased flexibility and accessibility in patient nutrition intake.

The new Probiotics Manufacturing Suite enables formulation with additional probiotic strains, new product concepts, and personalized wellness solutions.

Andrea Fuso, PhD, explains how B vitamins support brain energy metabolism, while SAMe drives neurotransmitter synthesis and methylation.

The Institute for the Advancement of Food and Nutrition Sciences (IAFNS) released nine principles to guide how foods are classified based on processing and formulation, aiming to improve consistency and transparency.

Best practices for clinical trial design to meet EFSA standards for scientific evidence. This means methodological honesty through clear hypotheses, proper controls, unbiased procedures, transparent reporting, and no manipulation of design or data to force an outcome.

How do recent population and clinical studies link omega-3 blood levels—particularly DHA and EPA—to brain, cardiovascular, mental, reproductive, and exercise health, and what do these findings suggest about the value of biomarkers, disease risk reduction, and future research needs?

Thomas Druke, senior marketing and business development manager at Balchem, explains why cognition is a crucial factor in sports performance, the opportunity this presents to dietary supplement manufacturers, and why choline is an ideal ingredient for supporting brain health in athletes.

In this interview, Aleix Sala-Vila, PhD, explains results from a recently published longitudinal study linking omega-3 levels and risk of early-onset dementia.

Isabelle Raymond, PhD, senior vice president, clinical and medical affairs at Nutrafol writes about how clinical research in the dietary supplement space requires a more tailored approach distinct from pharmaceutical trials.

In this interview, Andrea Fuso, PhD, explains how B vitamins influence methylation, antioxidant production, and SAMe synthesis through their role in one-carbon metabolism.

In this interview, Laura Allred, PhD, regulatory manager at the Gluten Free Certification Organization (GFCO), discusses ongoing concerns around gluten-free oat safety and explains why third-party certification remains critical regardless of potential regulatory changes.